samedan logo
 
 
 
spacer
home > ebr > autumn 2001 > editor's letter
PUBLICATIONS
European Biopharmaceutical Review

Editor's Letter

As we head towards the cooler weather, shorter days and bombardment of Autumn conferences, the annual BIO 2001 meeting in San Diego in June may seem like a long time ago. However, the memory of a marathon BIO with over 13,000 participants from all over the world, 700 exhibitors, 230 presenting companies and 15 conference tracks will probably stay with most of us for a long time to come. The sheer scale of the meeting and the buzz in the conference halls (and queues) reflected just how much the industry continues to grow and evolve in the post-2000 financing bonanza. Though times are now much tougher - with talk of recession on either side of the Atlantic, concern over the lack of leadership at the FDA, safety concerns, product withdrawals and manufacturing capacity problems (not forgetting the President Bush/stemcell/federal funding debate) - its not all doom and gloom for biotech. Many companies raised significant funds in the US and Europe last year and are now actively employing them in bringing products through development and negotiating higher value alliance deals with larger pharma partners. The pace of advance in science is also compelling and the blend of genomics, proteomics, informaticsand high throughput technologies is beginning to mature into new product development strategies.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Helen Abbott
spacer
Dr Helen Abbott
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Bio-Rad Launches Its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics

HERCULES, Calif.–October 21, 2021–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System
More info >>

White Papers

Securing the Global Pharmaceutical Supply Chain against the Threat of Counterfeit Drugs

World Courier

With a fully integrated GxP-compliant transport, storage and distribution system in place and over 140 wholly owned ISO 9001 - certified offices in more than 50 countries, WORLD COURIER, an AmerisourceBergen® company, is the world’s largest and most experienced provider of specialty courier services. It is uniquely positioned to meet the most demanding industry requirements for managing the global distribution of time - and temperaturesensitive pharmaceutical products and IMPs used commercially or in clinical trials.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement